RCAMU
ARNA

Rothschild & Co Asset Management US’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Rothschild & Co Asset Management US’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100,979
Closed -$9.38M – 282
2021
Q4 		$9.38M Sell
100,979
-121,945
-55% -$8.03M 0.11% 182
2021
Q3 		$13.3M Buy
222,924
+7,720
+4% +$456K 0.16% 150
2021
Q2 		$14.7M Buy
215,204
+49,436
+30% +$3.22M 0.17% 156
2021
Q1 		$11.5M Sell
165,768
-48,529
-23% -$3.73M 0.14% 180
2020
Q4 		$16.5M Sell
214,297
-33,133
-13% -$2.48M 0.21% 157
2020
Q3 		$18.5M Sell
247,430
-36,891
-13% -$2.46M 0.33% 130
2020
Q2 		$17.9M Buy
+284,321
New +$15.6M 0.26% 162

Rothschild & Co Asset Management US's ARNA Position: Q1 2022 in Review

Rothschild & Co Asset Management US sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 100,979 shares — an estimated $9.38M sold.

Rothschild & Co Asset Management US first reported a position in ARNA in Q2 2020 and held it in 7 quarters. The position peaked at $18.5M in Q3 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Rothschild & Co Asset Management US reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 100,979 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $9.38M.
  • Rothschild & Co Asset Management US first reported a position in Arena Pharmaceuticals Inc in Q2 2020 and held it in 7 quarters.
  • Rothschild & Co Asset Management US's Arena Pharmaceuticals Inc position peaked at $18.5M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Rothschild & Co Asset Management US's 13F filing for Q1 2022, filed 13 May 2022.